NOVELLO, SALVATORE
NOVELLO, SALVATORE
Dipartimento di Biologia - DiBio
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
2017 Longo, Francesco; Mercatelli, Daniela; Novello, Salvatore; Arcuri, Ludovico; Brugnoli, Alberto; Vincenzi, Fabrizio; Russo, Isabella; Berti, Giulia; Mabrouk, Omar S; Kennedy, Robert T; Shimshek, Derya R; Varani, Katia; Bubacco, Luigi; Greggio, Elisa; Morari, Michele
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
2018 Arcuri, L.; Novello, S.; Frassineti, M.; Mercatelli, D.; Pisano, C. A.; Morella, I.; Fasano, S.; Journigan, B. V.; Meyer, M. E.; Polgar, W. E.; Brambilla, R.; Zaveri, N. T.; Morari, M.
Autophagy and LRRK2 in the Aging Brain
2019 Albanese, F.; Novello, S.; Morari, M.
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
2018 Tozzi, A.; Durante, V.; Bastioli, G.; Mazzocchetti, P.; Novello, S.; Mechelli, A.; Morari, M.; Costa, C.; Mancini, A.; Di Filippo, M.; Calabresi, P.
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice
2022 Domenicale, Chiara; Mercatelli, Daniela; Albanese, Federica; Novello, Salvatore; Vincenzi, Fabrizio; Varani, Katia; Morari, Michele
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse
2021 Regoni, M.; Zanetti, L.; Comai, S.; Mercatelli, D.; Novello, S.; Albanese, F.; Croci, L.; Consalez, G. G.; Ciammola, A.; Valtorta, F.; Sassone, J.; Morari, M.
G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice
2018 Novello, S.; Arcuri, L.; Dovero, S.; Dutheil, N.; Shimshek, D. R.; Bezard, E.; Morari, M.
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
2020 Bourdenx, M.; Nioche, A.; Dovero, S.; Arotcarena, M. -L.; Camus, S.; Porras, G.; Thiolat, M. -L.; Rougier, N. P.; Prigent, A.; Aubert, P.; Bohic, S.; Sandt, C.; Laferriere, F.; Doudnikoff, E.; Kruse, N.; Mollenhauer, B.; Novello, S.; Morari, M.; Leste-Lasserre, T.; Damas, I. T.; Goillandeau, M.; Perier, C.; Estrada, C.; Garcia-Carrillo, N.; Recasens, A.; Vaikath, N. N.; El-Agnaf, O. M. A.; Herrero, M. T.; Derkinderen, P.; Vila, M.; Obeso, J. A.; Dehay, B.; Bezard, E.
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity
2022 Novello, S.; Mercatelli, D.; Albanese, F.; Domenicale, C.; Brugnoli, A.; D'Aversa, E.; Vantaggiato, S.; Dovero, S.; Murtaj, V.; Presotto, L.; Borgatti, M.; Shimshek, D. R.; Bezard, E.; Moresco, R. M.; Belloli, S.; Morari, M.
Lewy body-associated proteins: victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein
2021 Lashuel, H. A.; Novello, S.
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance
2021 Sarti, A. C.; Vultaggio-Poma, V.; Falzoni, S.; Missiroli, S.; Giuliani, A. L.; Boldrini, P.; Bonora, M.; Faita, F.; Di Lascio, N.; Kusmic, C.; Solini, A.; Novello, S.; Morari, M.; Rossato, M.; Wieckowski, M. R.; Giorgi, C.; Pinton, P.; Di Virgilio, F.
NOP receptor ligands and Parkinson’s disease
2019 Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M.
On-Demand Nanoliter Sampling Probe for the Collection of Brain Fluid
2022 Teixidor, J.; Novello, S.; Ortiz, D.; Menin, L.; Lashuel, H. A.; Bertsch, A.; Renaud, P.
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity
2020 Regoni, M.; Cattaneo, S.; Mercatelli, D.; Novello, S.; Passoni, A.; Bagnati, R.; Davoli, E.; Croci, L.; Consalez, G. G.; Albanese, F.; Zanetti, L.; Passafaro, M.; Serratto, G. M.; Di Fonzo, A.; Valtorta, F.; Ciammola, A.; Taverna, S.; Morari, M.; Sassone, J.
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
2022 Lashuel, H. A.; Mahul-Mellier, A. -L.; Novello, S.; Hegde, R. N.; Jasiqi, Y.; Altay, M. F.; Donzelli, S.; Deguire, S. M.; Burai, R.; Magalhaes, P.; Chiki, A.; Ricci, J.; Boussouf, M.; Sadek, A.; Stoops, E.; Iseli, C.; Guex, N.
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia
2018 Morari, M.; Brugnoli, A.; Pisano, C. A.; Novello, S.; Caccia, C.; Melloni, E.; Padoani, G.; Vailati, S.; Sardina, M.
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
2020 Pisano, C. A.; Brugnoli, A.; Novello, S.; Caccia, C.; Keywood, C.; Melloni, E.; Vailati, S.; Padoani, G.; Morari, M.
Safinamide modulates striatal glutamatergic signaling in a rat model of levodopa-induced dyskinesia
2018 Gardoni, F.; Morari, M.; Kulisevsky, J.; Brugnoli, A.; Novello, S.; Pisano, C. A.; Caccia, C.; Mellone, M.; Melloni, E.; Padoani, G.; Sosti, V.; Vailati, S.; Keywood, C.